Sun Pharma Extends Offer For Taro Shares In Ongoing Rocky Affair
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Sun Pharmaceutical has extended the tender offer for purchase of all outstanding ordinary shares of Israeli drug maker Taro Pharmaceuticals until September 2
You may also be interested in...
Advantage Sun Pharma As Tel Aviv Court Rules Out Special Tender Offer For Taro Shares
MUMBAI - Sun Pharmaceutical has emerged victorious in the protracted battle with Taro Pharmaceutical in its bid to acquire control of the Israel headquartered company. A Tel Aviv District Court rejected Taro's contention for a special tender offer under Israeli law before Sun Pharma could proceed with its objective to gain control of Taro management
Advantage Sun Pharma As Tel Aviv Court Rules Out Special Tender Offer For Taro Shares
MUMBAI - Sun Pharmaceutical has emerged victorious in the protracted battle with Taro Pharmaceutical in its bid to acquire control of the Israel headquartered company. A Tel Aviv District Court rejected Taro's contention for a special tender offer under Israeli law before Sun Pharma could proceed with its objective to gain control of Taro management
War Of Words Back Between Taro, Sun Pharma; Both Vow to Wrest Taro Control
MUMBAI - The battle for control of Israeli generic drug maker Taro is set to heat up further as Indian drug maker Sun Pharmaceuticals and Taro separately vowed their resolve to retain and acquire control of the beleaguered company